| Bioactivity | mTORC1-IN-2 (compound H3) is a NO donor compound that alleviates vasodilation and attenuates myocardial hypoxic injury. mTORC1-IN-2 upregulates TSC2-P expression and inhibits mTORC1 expression[1]. |
| Target | mTORC1 |
| Name | mTORC1-IN-2 |
| CAS | 2974368-96-0 |
| Formula | C16H15N3O6 |
| Molar Mass | 345.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yang W et al. Discovery of Efficient Hypoxia-Targeted NO Donor Compounds to Alleviate Hypoxia Cardiac Disease. J Med Chem. 2023 Nov 16. |
mTORC1-IN-2
CAS: 2974368-96-0 F: C16H15N3O6 W: 345.31
mTORC1-IN-2 (compound H3) is a NO donor compound that alleviates vasodilation and attenuates myocardial hypoxic injury.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.